Skip to main content
. 2024 Apr 23;43(2):257-264. doi: 10.5937/jomb0-45083

Table 3. The level of investigated biomarkers in serum and CSF in the MS group.

NFs – neurofilaments in cerebrospinal fluid; GDF-15 – Growth differentiation factor 15 in serum

MS group with stationary<br>MRI findings (n=30) MS group with progression<br>of MRI findings (n=30) p-value
cNFs 0.20 (0.11–1.29) 0.30 (0.27–1.42) 0.820
sGDF15 183 (25–760) 172 (46–460) 0.782